Tubot, Cristina C.
HRN: 23-46-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/20/2023
09/10/2023
IV
4.5 G
Q8h
Breast CA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes